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Figure 2.1. Rooibos growing in the Cederberg region of South Africa [www.rooibosltd.co.za]. 
 
2.3 Processing 
 
Rooibos made a successful transition from a wild to a cultivated crop and is one of the few 
economically important fynbos plants. Rooibos seeds are sown from February to March and 
seedlings are replanted during July and August in the Southern hemisphere winter period. Only 
the top half of the plant is cut, with about 30 cm left above the soil (figure 2.2). It is vital to make 
sure that healthy leaves remain on the plant after harvesting or else the plant will not survive. In 
addition during the second year of harvesting, the plant should not be cut below the height 
harvested the previous year. It is best to harvest slightly higher each year for new growth can 
come from the previous season’s wood. Rooibos is harvested once a year between December and 
April [www.asnapp.org.za]. 
 
As previously mentioned rooibos was harvested with axes by the Khoi-Khoi tribe —bruised, 
fermented and dried in the sun [Wilson, 2005]. Today rooibos is still processed in a similar 
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manner, although the process has been mechanized. Processing is carried out in two different 
ways to produce the two types of tea — after harvesting, the leaves and stems are either bruised 
and fermented to produce the traditional fermented rooibos or immediately dried to prevent 
oxidation, producing unfermented rooibos. Before packaging, the dry product is sterilized by 
steam pasteurization [Standley et al., 2001]. 
 
Rooibos tea is referred to as fermented tea since the polyphenols are oxidized during the 
fermentation process, resulting in the changing of the color of the leaves from green to red. The 
resulting tea is a rich orange/red color and it is this distinctive color that led to the African name 
rooibos, which means “red bush” [McKay and Blumberg, 2007; Erickson, 2003]. The 
unfermented rooibos, also called green rooibos, contains higher levels of polyphenol antioxidants 
than its fermented counterpart [Joubert, 1996]. 
 
 
Figure 2.2. Mature rooibos plant [reproduced from Agribussiness in sustainable natural African plant 
products, Crop profile, www.asnapp.org.za].  
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Figure 3.5. Systemic effects of the stress hormones glucocorticoids and catecholamines secreted by the 
adrenal gland and norepinephrine released by sympathetic nerve terminals. Solid lines indicated stimulation 
and dashed lines indicated inhibition. NK, natural-killer cells; MO, macrophage; Th1, T-helper lymphocyte 
type 1 cells; Th2, T-helper lymphocyte type 2 cells; TNF, tumour necrosis factor [Vissoci Reichea et al., 2004].  
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In this study four extracts, methanol and aqueous extracts of fermented and unfermented rooibos, 
were prepared and the inhibition of PROG binding to microsomal P450 enzymes subsequently 
assayed. The extracts inhibited the binding of PROG with the unfermented extracts exhibiting a 
greater inhibitory effect that the fermented extracts (figure 5.4). The inhibition of PROG binding 
by the unfermented rooibos methanol and aqueous extracts was greater than 35 % (P<0.001).   
 
The lowest inhibition was obtained with the fermented rooibos aqueous extract which inhibited 
the binding of PROG by 13 % (P<0.05) with the fermented rooibos methanol extract inhibiting 
PROG binding by 27 % (P<0.01). The inhibition of PROG binding by the unfermented rooibos 
aqueous extract was significantly higher (P<0.001) than the inhibition of fermented rooibos 
methanol and aqueous extracts. The final concentration of the unfermented rooibos aqueous and 
methanol extracts were 0.74 mg/ml and 0.72 mg/ml respectively. The final concentration of the 
fermented rooibos methanol and aqueous extracts were both 0.73 mg/ml.  
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Figure 5.3. A) Inhibition of PROG-induced type I difference spectra in ovine adrenal microsomes ([P450] = 
0.8 µM) and B) percentage inhibition of PROG binding in the presence of rooibos extracts. [PROG] = 16 µM; 
[unfermented rooibos aqueous extract] = 0.74 mg/ml; [unfermented rooibos methanol extract] = 0.72 mg/ml; 
[fermented aqueous extract] = 0.73 mg/ml, and [fermented rooibos methanol extract] = 0.73 mg/ml. are 
presented as the mean, error bars represent SEM and n=3. Inhibition of PROG by the extracts was analysed 
by a one-way ANOVA, followed by Bonferroni's multiple comparison test. 
 
95 
 
 
The inhibition of aqueous extracts of the unfermented rooibos on the binding of PROG and 
17OH-PROG to adrenal microsomal P450 enzymes was investigated using varying 
concentrations of substrate (2 – 32 µM) and extracts (final concentrations, 0.184 – 0.736 mg/ml). 
The inhibition of PROG (2µM) and 17OH-PROG (2µM) binding to microsomal P450 enzymes 
in the presence of 2µl of the aqueous extract of unfermented rooibos (final concentration of 
0.736 mg/ml) was 29.4 % and 10 %, respectively (figure 5.4).  
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Figure 5.4. Inhibition of steroid-induced type I difference spectra in ovine adrenal microsomes. [P450] = 0.8 
µM; A) [PROG] = 2 µM; [unfermented rooibos aqueous extract] = 0.184 mg/ml and B) [17OH-PROG] = 2 
µM;[unfermented aqueous extract] = 0.184 mg/ml. 
 
The data obtained from the assays determining the degree of inhibition of PROG and 17OH-
PROG at various substrate and extract concentrations generated hyperbolic saturation binding 
curves (figure 5.5).  It can be seen from the data that the maximum substrate binding capacity 
(Bmax) of the microsomal enzymes differs markedly. This may be due to the fact that the 
microsomal preparation contains both CYP17 and CYP 21 enzymes and while PROG and 
17OH-PROG are both natural substrates for CYP21, CYP17 catalyses only the conversion of 
PROG showing negligible catalytic activity towards 17OH-PROG.  
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Figure 5.5. Hyperbolic saturation binding curves of die inhibitory effect of unfermented rooibos aqueous 
extract on A) PROG and B) 17OH-PROG binding to microsomal P450 enzymes. [P450] = 0.8 µM; [Prog] and 
[17OH-PROG] = 2 – 32 µM; [unfermented rooibos aqueous extracts] =   0.184 – 0.736 mg/ml. Results are 
presented as the mean, error bars represent SEM and n=3. 
 
Double reciprocal plots, a convenient linearization of Michaelis-Menten data, were plotted to 
visualize the inhibition data. It appears that in the presence of unfermented rooibos aqueous 
extracts, the binding of PROG to the P450 enzymes is being competitively inhibited as only the 
Ki (binding inhibition constant) changes (figure 5.6). It is possible for compounds in the extracts 
to bind to the enzymes or to the enzyme-substrate complex and thus mixed inhibition of binding 
was also analysed. The secondary plots are shown in figure 5.7. Analysis of the data revealed K′i 
(apparent inhibition constant for the binding of E + I) and Ki (inhibition constant for the binding 
of ES + I), to be 1.3 mg/ml (figure 5.7 A and B). The binding of PROG to the microsomal 
enzymes appears to be competitively inhibited in the presence of the concentrations assayed for 
unfermented rooibos aqueous extracts.  
 
The double reciprocal plot of 17OH-PROG binding shows that 17OH-PROG is being 
competitively inhibited at low concentrations of extract with uncompetitive or mixed inhibition 
occurring at higher concentrations (figure 5.8). Analysis of the data (figure 5.9 A and B) revealed 
that the Ki and the K′i values, 0.08 and 1.9 mg/ml do indicate mixed inhibition of the binding of 
17OH-PROG to the microsomal enzymes by unfermented rooibos aqueous extracts. 
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Figure 5.6. Double reciprocal plot of the inhibitory effect of unfermented rooibos aqueous extract on PROG 
binding. [P450] = 0.8 µM; [PROG] = 2 – 32 µM; unfermented rooibos aqueous extract = [0.184 – 0.736 
mg/ml]. Results are presented as the mean of 3 independent experiments. 
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Figure 5.7. Secondary plots for inhibition of PROG binding to microsomal P450 enzymes in the presence of 
unfermented rooibos aqueous extract A) plot of 1/Bappmax against extract concentration and B) plot of Km/ 
Bappmax. [P450] = 0.8 µM; [17OH-PROG] = 2 – 32 µM; unfermented rooibos aqueous extract [0.184 – 0.736 
mg/ml]. Results are presented as the mean of 3 independent experiments. 
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Figure 5.8. Double reciprocal plot of the inhibitory effect of unfermented rooibos aqueous extract on 17OH-
PROG binding. [P450] = 0.8 µM; [17OH-PROG] = 2 – 32 µM; unfermented rooibos aqueous extract = [0.184 
– 0.736 mg/ml]. Results are presented as the mean of 3 independent experiments. 
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Figure 5.9. Secondary plots for mixed inhibition of 17OH-PROG binding to microsomal P450 enzymes in the 
presence of unfermented rooibos aqueous extract A) plot of 1/Bappmax against extract concentration and B) 
plot of Km/ Bappmax. [P450] = 0.8 µM; [0.184 – 0.736 mg/ml]. Results are presented as the mean of 3 
independent experiments. 
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Figure 5.10. Metabolism of PREG (10 µM) by ovine adrenal microsomal P450 enzymes ([P450] = 0.35 µM) 
after initiation with NADPH (1 mM). (A) Percentage conversion in the absence of rooibos extracts and (B) 
percentage inhibition of PREG (after 15 min) in the presence of rooibos extracts. Unfermented rooibos: 
[aqueous extract] = 2.3 mg/ml, methanol extract = 2.3 mg/ml); fermented rooibos: [aqueous extract] = 2.3 
mg/ml and methanol extract = 2.3 mg/ml. Results are presented as the mean, error bars represent SEM and 
n=3.  Inhibition of PREG metabolism by the extracts was analysed by a one-way ANOVA, followed by 
Bonferroni's multiple comparison test. 
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Figure 5.11. HPLC analysis of PREG (10 μM) metabolism by ovine adrenal microsomes at 10 min. Peak 1, 
PREG (7.5 min); peak 2, 17OH-PREG (3.5 min); and peak 3, DHEA (2.2 min). 
 
In adrenal microsomes, the conversion of PROG to its subsequent metabolites is catalyzed by 
both CYP17 and CYP21. The conversion of PROG to 17OH-PROG is catalyzed by CYP17 
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Figure 5.12.  Metabolism of PROG (10 µM) by CYP17 and CYP21 ([P450] = 0.35 µM) in ovine adrenal 
microsomes after initiation with NADPH (1 mM) to deoxycortisol, DOC and 17OH-PROG metabolites. (A) 
Percentage conversion in the absence of rooibos extracts and (B) percentage inhibition of PROG conversion 
(after 15 min) in the presence of rooibos extracts. Unfermented rooibos: [aqueous extract] = 2.275 mg/ml, 
methanol extract = 2.25 mg/ml); fermented rooibos: [aqueous extract] = 2.3 mg/ml and methanol extract = 2.3 
mg/ml. Results are presented as the mean, error bars represent SEM and n=3.  Inhibition of PROG 
metabolism by the extracts was analysed by a one-way ANOVA, followed by Bonferroni's multiple 
comparison test. 
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Figure 5 .13. HPLC analysis of PROG (10 μM) metabolism by ovine adrenal microsomes at 10 min. Peak 1, 
PROG (23 min); peak 2, 17-OH-PROG (19.5 min); peak 3, DOC (16.8 min); and peak 4, deoxycortisol (10 
min). 
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Figure 5.14. Conversion of PROG (10 µM) to steroid metabolites DOC, 17OH-PROG and deoxycortisol in the 
absence and presence of fermented rooibos aqueous extract in ovine adrenal microsomes [P450] = 0.35 µM) 
after initiation with NADPH (1 mM); [Fermented rooibos aqueous extract] = 2.3 mg/ml. Results are 
presented as the mean, error bars represent SEM and n=3. 
 
5.3.4 COS1 conversion assay 
 
The influence of rooibos extracts on the catalytic activity of the individual enzymes was 
investigated by expressing CYP17 and CYP21 in COS1 cells.  
 
Baboon CYP17 expressed in COS1 cells, in the absence of rooibos extracts, converted 97 % 
PROG to 17OH-PROG and negligible amounts 4-androstenedione. In the presence of the 
unfermented rooibos methanol extract, the conversion of PROG to its metabolites was 
significantly inhibited (P<0.001) with 41 % being converted. PROG conversion in the presence 
of the fermented rooibos methanol extract was inhibited to a lesser degree, 39 % (P<0.01). 
Results are illustrated in figure 5.15 A.  
 
In COS1 cells expressing baboon CYP21 70 % PROG was converted to DOC in the absence of 
rooibos extracts. Both unfermented and fermented rooibos methanol extracts inhibited the 
conversion of PROG to DOC significantly (P<0.001), with 30% DOC being formed (figure 5.15 
B). 
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Figure 5.15. Percentage inhibition of PROG (1 µM) metabolism in COS1 cells expressing A) baboon CYP17 
and B) baboon CYP 21 in the presence of methanol extracts of unfermented and fermented rooibos. 
[Unfermented rooibos methanol extract] = 4.5 mg/ml; [fermented rooibos methanol extract] = 4.6 mg/ml. 
Results are presented as the mean, error bars represent SEM and n=3. Inhibition of PROG metabolism by 
the extracts was analysed by a one-way ANOVA, followed by Bonferroni's multiple comparison test. 
 
Steroid metabolites were analysed using LC-MS. The elution profile of PROG and DOC 
standards is shown in figure 5.16. Stock solutions of PROG and DOC (2 mg/ml ethanol) were 
used to prepare a series of standards, (2, 20, 200, and 2000 ng/ml) in methanol from the stock 
solutions. A standard curve was generated for each steroid with concentrations ranging from 10 
to 1000 ng/ml. The calibration curves were linear over these concentration ranges (r2 better than 
0.99). 
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Figure 5.22.  Percentage inhibition of PROG (1 µM) metabolism in COS1 cells expressing baboon CYP21 in 
the presence of rooibos flavonoid compounds rutin, vitexin and orientin. [Rutin] = 3 and 10 µM; [vitexin] = 3 
and 10 µM; [orientin] = 3 and 10 µM. Results are presented as the mean, error bars represent SEM and n=3. 
Inhibition of PROG metabolism by the compounds was analysed by a one-way ANOVA, followed by 
Bonferroni's multiple comparison test (p < 0.001). 
 
5.4 Discussion 
 
The bioactivity of unfermented and fermented rooibos extracts was investigated by determining 
the influence on P450 enzymes, CYP17 and CYP21. These enzymes are at a branch point in 
adrenal steroidogenesis and their inhibition would affect the outcome of adrenal steroidogenesis. 
The binding of endogenous substrate to the enzymes and subsequent substrate conversion were 
thus assayed. Once activity had been established, the methanol extract of unfermented rooibos 
was fractionated and individual fractions were assayed to determine the inhibition of the binding 
of substrates to CYP17 and CYP21 as well as the catalytic activity of these enzymes. The 
influence of flavonoid compounds present in the fractions on the catalytic activity of CYP21 was 
subsequently assayed.  
 
